We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




First Surgery Using Commercial Stem Cell-Derived Heart Muscle Sheets Performed in Japan

By HospiMedica International staff writers
Posted on 05 Oct 2026

Ischemic heart disease causes damage when narrowed coronary arteries restrict blood flow to the heart. More...

For patients who have exhausted other treatment options, persistent symptoms, reduced cardiac function, and limited exercise tolerance remain major concerns. Addressing this need, a Japanese hospital has performed the first surgery using commercially available sheets of stem cell-derived heart muscle cells.

At Osaka Keisatsu Hospital (Osaka, Japan), surgeons transplanted the cell sheets into the heart of a woman in her 50s. The operation, performed on September 29, 2026, lasted about an hour. It was the first clinical use of the therapy since it received conditional approval from the Japanese government in March 2026.

The sheets contain heart muscle cells derived from induced pluripotent stem (iPS) cells. These cells are created by returning mature, specialized cells to an earlier developmental state. They can then develop into different cell types. The therapy is intended primarily for heart patients who have exhausted other treatment options.

Trials of the therapy involved eight patients with ischemic heart disease. All eight experienced relief of symptoms, while four also showed improved heart function, according to Japanese media reports. The treatment is expected to improve heart muscle function, heart failure symptoms, cardiac performance, and exercise tolerance, although those broader outcomes have not yet been established.

The team plans to perform similar operations on 75 patients by 2033 and report on the treatment’s efficacy. Full authorization would depend on evidence of benefit and safety gathered over the next seven years. Japan also conditionally approved a separate iPS-cell treatment for Parkinson’s disease in March 2026. That treatment involves transplanting cells into a patient’s brain and was approved following a successful clinical trial.


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gas Analyzer
GE SAM
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
From left: Mr Ng Tian Chong, Chief Executive Officer, Singtel Singapore; Professor Yeoh Khay Guan, Chief Executive, NUHS; and Mr Daniel Ode, Head of Ericsson Singapore, Brunei and Philippines and Global Customer Unit Singtel, signed a Memorandum of Understanding to advance connected healthcare, 5G-Advanced and 6G technology, as well as connected intelligence. (Photo courtesy of National University Health System)

Healthcare Partnership Creates Testbed for Advanced Connectivity and AI Applications

Hospitals face growing care complexity, aging populations, and pressure to extend monitoring beyond traditional inpatient settings. Meeting these demands requires more responsive clinical workflows and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.